Charles Brenner, Ph.D., is the Alfred E Mann Family Foundation Chair in Diabetes and Cancer Metabolism at City of Hope and Chief Scientific Advisor at Niagen Bioscience. Brenner is the leading global scholar on the topic of synthesis, regulation and quantification of NAD coenzymes and NAD metabolites in health and disease. Dr. Brenner also led the first clinical trial of NR, which established safe oral availability in humans. Brenner collaborates with research groups globally who are investigating activities of NR in reducing inflammation and improving human health and resistance to disease. #LELearn #EDULiveforeverish